Use cases

Synthetic control arms

Synthetic control arms (SCAs) can help improve clinical trial effectiveness, especially for rare diseases with low participant numbers, or for conditions  where the use of a placebo or comparator therapy may be considered unethical. SCAs reduce time and cost of clinical trials and can enhance the effectiveness of single arm trials. 

SENSIGHT’s proprietary tools can be used to define patient cohorts by multiple criteria and build control arms in the platform, helping users to:

Conduct feasibility analyses for running SCAs

Improve understanding of inclusion and exclusion criteria

Provide input into clinical trial design feasibility

Create comparator arm using real world data from a wide variety of sources

Imaging report analysis

SENSIGHT offers an added level of data analysis sophistication with AI interpretation of radiology reports, providing a deeper level of insight into pathology including patient stratification, patient progression analysis and outcome prediction.